The filing shows a mixed picture: improving revenue and narrowing operating loss from continuing operations, but a worsening Adjusted EBITDA and a massive net loss from discontinued operations. The balance sheet strengthening and acquisition provide a positive narrative, but the company remains deeply unprofitable with a $2M market cap. Monitor for the next quarterly filing to see if organic growth initiatives and the Family Beginnings acquisition translate into improving cash flows.
Price Chart
Executive Summary
INVO Fertility reported FY2025 revenue of $6.84M (+5% YoY) and a net loss from continuing operations of $(5.3)M, improved from $(7.7)M in FY2024. The company highlighted a strengthened balance sheet with $11.5M in recent financing, the acquisition of Family Beginnings, and the elimination of Series C-2 Preferred and warrant liabilities. However, Adjusted EBITDA worsened to $(3.2)M from $(2.2)M, and the net loss attributable to common shareholders was $(25.1)M due to discontinued operations and warrant deemed dividends.
Key Financial Metrics
Key Facts
- FY2025 revenue of $6,841,250, up 5% from $6,532,000 in FY2024.
- Net loss from continuing operations improved to $(5.3)M from $(7.7)M.
- Adjusted EBITDA worsened to $(3.2)M from $(2.2)M.
- Closed acquisition of Family Beginnings in February 2026, adding ~$1.2M in trailing revenue.
- Raised $11.5M in gross proceeds from December 2025 and January 2026 financings.
- All Series C-2 Preferred converted or retired; warrant liabilities eliminated.
- Net loss attributable to common shareholders was $(25.1)M, including $(16.5)M from discontinued operations and $(1.8)M in warrant deemed dividends.
- Weighted average basic shares outstanding: 117,083 in FY2025 vs 2,514 in FY2024.
Financial Impact
Revenue growth of 5% to $6.84M; net loss from continuing ops improved by ~31% to $(5.3)M; Adjusted EBITDA declined by 41% to $(3.2)M.
Risk Factors
- Continued operating losses and negative Adjusted EBITDA.
- Massive net loss from discontinued operations ($16.5M) and warrant deemed dividends ($1.8M).
- Extremely low market cap ($2M) and thin trading liquidity.
- Dependence on future acquisitions and financing for growth.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026777 |
| Document: form8-k.htm | 0001493152-26-026777 |
| Document: 0001493152-26-026777-index-headers.html | 0001493152-26-026777 |
| Document: 0001493152-26-026777-index.html | 0001493152-26-026777 |
| Document: 0001493152-26-026777.txt | 0001493152-26-026777 |
| 8-K Data (Synthetic) | 0001493152-26-026777 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | SC 13G/A | $0.7275 $0.5576 | ▲ +23.35% | ▲ +21.39% | $0.5842 (+19.70%) |
Aug 28, 2026 8w ago | 8-K | $1.00 $0.9850 | ▲ +1.50% | ▲ +1.61% | $0.5842 (+41.58%) |
Aug 17, 2026 10w ago | 8-K | $1.53 $1.03 | ▼ −32.68% | ▼ −31.49% | $0.5842 (−61.82%) |
Aug 17, 2026 10w ago | Press Release | $1.53 $1.03 | ▲ +32.68% | ▲ +31.49% | $0.5842 (+61.82%) |
Aug 5, 2026 11w ago | EFFECT | $1.08 $1.01 | ▲ +6.05% | ▲ +6.40% | $0.5842 (+45.66%) |
Jun 25, 2026 17w ago | 8-K | $2.45 $1.62 | ▼ −33.88% | ▼ −36.04% | $0.5842 (−76.16%) |
Jun 22, 2026 18w ago | Press Release | $1.39 $2.45 | ▼ −76.26% | ▼ −78.33% | $0.5842 (+57.97%) |
Jun 16, 2026 18w ago | 8-K | $1.59 $1.32 | ▼ −16.98% | ▼ −15.94% | $0.5842 (−63.26%) |
Jun 2, 2026 20w ago | Press Release | $1.70 $1.41 | ▲ +17.06% | ▲ +13.24% | $0.5842 (+65.64%) |
Jun 2, 2026 21w ago | 8-K | $1.52 $1.40 | ▼ −7.89% | ▼ −4.93% | $0.5842 (−61.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers